Back to Results
First PageMeta Content
Glaucoma / Ethers / Alcohols / Beta blockers / Amines / Dorzolamide/timolol / Timolol / Dorzolamide / Merck & Co. / Chemistry / Medicine / Organic chemistry


News Release Santen Announces Approval of Glaucoma and Ocular Hypertension Therapeutic, COSOPT Mini Ophthalmic Solution in Japan Osaka, Japan, March 12, 2015Santen Pharmaceutical Co., Ltd. (hereafter
Add to Reading List

Open Document

File Size: 142,59 KB

Share Result on Facebook

City

Tokyo / Osaka / /

Company

Merck & Co. Inc. / Merck USA / Santen Pharmaceutical Co. Ltd. / /

Country

Japan / United States / /

/

Event

FDA Phase / /

Facility

Whitehouse Station / /

IndustryTerm

ophthalmic solution / pharmaceuticals / combination ophthalmic solution / manufacturing / ophthalmic pharmaceutical market / preservative-free solution / /

MedicalCondition

Glaucoma / disease / severe conjunctival epithelial disorder / optic nerve disorder / chronic disease / ocular hypertension / visual field disorder / blindness / /

Organization

Ministry of Health / /

Person

Takashi Hibi / /

/

Position

General Manager Corporate Communication Group / /

Product

TRUSOPT / COSOPT / timolol maleate / COSOPT Mini Ophthalmic Solution / COSOPT Mini Combination Ophthalmic Solution / /

SocialTag